Helius Medical’s PoNS Receives the US FDA’s Approval to Improve Gait in Multiple Sclerosis Patients

Shots:

• The approval is based on two clinical studies and a retrospective analysis of RWD. The device is intended to be used by prescription only as an adjunct to a supervised therapeutic exercise program in patients aged ⥸22yrs.
• The approval will help in improving the walking gait of people with MS in combination with a therapeutic program for exercise and balance
• PoNS  is a neuromuscular tongue stimulator that consists of a non-implantable apparatus to generate electrical pulses for stimulation of the trigeminal and facial nerves via the tongue to provide treatment of motor deficits

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Helius